GENEVA, July 6, 2023 — The Human Immunome Project’s (HIP) Board Chair Jane Metcalfe and CEO Hans Keirstead spoke today at the AI for Good Global Summit detailing how decoding and building an AI model of the immune system can revolutionize how we address disease and enable everyone to live longer, healthier lives.
Read MoreMichelson Prize Winners Collaborate on New, $9.5M Emerging Pathogens Project
Young researchers are often at the cutting-edge of scientific discovery, yet they struggle to find funding to support their efforts. The Michelson Prizes: Next Generation Grants are designed to fill this gap and reward young scientists pursuing innovative research to advance human immunology, vaccine discovery, and immunotherapy for global diseases. The grants, a partnership between…
Read MoreMeet Our New CEO: Dr. Hans Keirstead
The scientist and serial entrepreneur takes over the reigns of the Human Immunome Project, bringing decades of leadership and fundraising experience. Interview by Kristen Jill Abboud
Read MoreHuman Immunome Project Announces New Leadership
NEW YORK, MAY 22, 2023 — The Human Immunome Project has undertaken an internal restructuring to expand and accelerate its capacity to execute on the focused initiatives that serve health care stakeholders worldwide. As part of this restructuring, Founder Dr. Wayne Koff has retired from his full-time role as Chief Executive Officer. He will remain an…
Read MoreMeasuring Your Immune Age: Beyond the Calendar
In 2019, a pre-eminent group of scientists including HIP Scientific Partner Network member Mark Davis and Co-Chief Science Officer Shai Shen-Orr published “A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring” in Nature Medicine. Your immune system ages, but not necessarily at the same rate as your chronological age. Researchers followed 135…
Read More